Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer

NCT03587129 is registered in ClinicalTrials.gov with First Affiliated Hospital of Harbin Medical University as lead sponsor.

NCT NCT03587129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03587129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Apatinib in the Treatment of Platinum Resistant Recurrent Ovarian Cancer
Lead sponsor
First Affiliated Hospital of Harbin Medical University
Phase
Phase 2
Overall status
Terminated
Start date
July 10, 2018
Completion date
June 14, 2020
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer